Stem cell factor improves lung recovery in rats following neonatal hyperoxia-induced lung injury

Luis F. Miranda, Claudia O. Rodrigues, Shalini Ramachandran, Eneida Torres, Jian Huang, Jammie Klim, Dorothy Hehre, Ian McNiece, Joshua M. Hare, Cleide Y. Suguihara, Karen C. Young

Research output: Contribution to journalArticle

Abstract

Background: Stem cell factor (SCF) and its receptor, c-kit, are modulators of angiogenesis. Neonatal hyperoxia-induced lung injury (HILI) is characterized by disordered angiogenesis. The objective of this study was to determine whether exogenous SCF improves recovery from neonatal HILI by improving angiogenesis. Methods: Newborn rats assigned to normoxia (RA: 20.9% O2) or hyperoxia (90% O2) from postnatal day (P) 2 to 15, received daily injections of SCF 100 μg/kg or placebo (PL) from P15 to P21. Lung morphometry was performed at P28. Capillary tube formation in SCF-treated hyperoxia-exposed pulmonary microvascular endothelial cells (HPMECs) was determined by Matrigel assay. Results: As compared with RA, hyperoxic-PL pups had decrease in alveolarization and in lung vascular density, and this was associated with increased right ventricular systolic pressure (RVSP), right ventricular hypertrophy, and vascular remodeling. In contrast, SCF-treated hyperoxic pups had increased angiogenesis, improved alveolarization, and attenuation of pulmonary hypertension as evidenced by decreased RVSP, right ventricular hypertrophy, and vascular remodeling. Moreover, in an in vitro model, SCF increased capillary tube formation in hyperoxia-exposed HPMECs. Conclusion: Exogenous SCF restores alveolar and vascular structure in neonatal rats with HILI by promoting neoangiogenesis. These findings suggest a new strategy to treat lung diseases characterized by dysangiogenesis.

Original languageEnglish (US)
Pages (from-to)682-688
Number of pages7
JournalPediatric Research
Volume74
Issue number6
DOIs
StatePublished - Dec 2013
Externally publishedYes

Fingerprint

Hyperoxia
Stem Cell Factor
Lung Injury
Lung
Right Ventricular Hypertrophy
Ventricular Remodeling
Ventricular Pressure
Blood Vessels
Angiogenesis Modulating Agents
Endothelial Cells
Placebos
Proto-Oncogene Proteins c-kit
Blood Pressure
Pulmonary Hypertension
Lung Diseases
Injections

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Miranda, L. F., Rodrigues, C. O., Ramachandran, S., Torres, E., Huang, J., Klim, J., ... Young, K. C. (2013). Stem cell factor improves lung recovery in rats following neonatal hyperoxia-induced lung injury. Pediatric Research, 74(6), 682-688. https://doi.org/10.1038/pr.2013.165

Stem cell factor improves lung recovery in rats following neonatal hyperoxia-induced lung injury. / Miranda, Luis F.; Rodrigues, Claudia O.; Ramachandran, Shalini; Torres, Eneida; Huang, Jian; Klim, Jammie; Hehre, Dorothy; McNiece, Ian; Hare, Joshua M.; Suguihara, Cleide Y.; Young, Karen C.

In: Pediatric Research, Vol. 74, No. 6, 12.2013, p. 682-688.

Research output: Contribution to journalArticle

Miranda, LF, Rodrigues, CO, Ramachandran, S, Torres, E, Huang, J, Klim, J, Hehre, D, McNiece, I, Hare, JM, Suguihara, CY & Young, KC 2013, 'Stem cell factor improves lung recovery in rats following neonatal hyperoxia-induced lung injury', Pediatric Research, vol. 74, no. 6, pp. 682-688. https://doi.org/10.1038/pr.2013.165
Miranda LF, Rodrigues CO, Ramachandran S, Torres E, Huang J, Klim J et al. Stem cell factor improves lung recovery in rats following neonatal hyperoxia-induced lung injury. Pediatric Research. 2013 Dec;74(6):682-688. https://doi.org/10.1038/pr.2013.165
Miranda, Luis F. ; Rodrigues, Claudia O. ; Ramachandran, Shalini ; Torres, Eneida ; Huang, Jian ; Klim, Jammie ; Hehre, Dorothy ; McNiece, Ian ; Hare, Joshua M. ; Suguihara, Cleide Y. ; Young, Karen C. / Stem cell factor improves lung recovery in rats following neonatal hyperoxia-induced lung injury. In: Pediatric Research. 2013 ; Vol. 74, No. 6. pp. 682-688.
@article{e4a23235e3b241b8900307815adecf42,
title = "Stem cell factor improves lung recovery in rats following neonatal hyperoxia-induced lung injury",
abstract = "Background: Stem cell factor (SCF) and its receptor, c-kit, are modulators of angiogenesis. Neonatal hyperoxia-induced lung injury (HILI) is characterized by disordered angiogenesis. The objective of this study was to determine whether exogenous SCF improves recovery from neonatal HILI by improving angiogenesis. Methods: Newborn rats assigned to normoxia (RA: 20.9{\%} O2) or hyperoxia (90{\%} O2) from postnatal day (P) 2 to 15, received daily injections of SCF 100 μg/kg or placebo (PL) from P15 to P21. Lung morphometry was performed at P28. Capillary tube formation in SCF-treated hyperoxia-exposed pulmonary microvascular endothelial cells (HPMECs) was determined by Matrigel assay. Results: As compared with RA, hyperoxic-PL pups had decrease in alveolarization and in lung vascular density, and this was associated with increased right ventricular systolic pressure (RVSP), right ventricular hypertrophy, and vascular remodeling. In contrast, SCF-treated hyperoxic pups had increased angiogenesis, improved alveolarization, and attenuation of pulmonary hypertension as evidenced by decreased RVSP, right ventricular hypertrophy, and vascular remodeling. Moreover, in an in vitro model, SCF increased capillary tube formation in hyperoxia-exposed HPMECs. Conclusion: Exogenous SCF restores alveolar and vascular structure in neonatal rats with HILI by promoting neoangiogenesis. These findings suggest a new strategy to treat lung diseases characterized by dysangiogenesis.",
author = "Miranda, {Luis F.} and Rodrigues, {Claudia O.} and Shalini Ramachandran and Eneida Torres and Jian Huang and Jammie Klim and Dorothy Hehre and Ian McNiece and Hare, {Joshua M.} and Suguihara, {Cleide Y.} and Young, {Karen C.}",
year = "2013",
month = "12",
doi = "10.1038/pr.2013.165",
language = "English (US)",
volume = "74",
pages = "682--688",
journal = "Pediatric Research",
issn = "0031-3998",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Stem cell factor improves lung recovery in rats following neonatal hyperoxia-induced lung injury

AU - Miranda, Luis F.

AU - Rodrigues, Claudia O.

AU - Ramachandran, Shalini

AU - Torres, Eneida

AU - Huang, Jian

AU - Klim, Jammie

AU - Hehre, Dorothy

AU - McNiece, Ian

AU - Hare, Joshua M.

AU - Suguihara, Cleide Y.

AU - Young, Karen C.

PY - 2013/12

Y1 - 2013/12

N2 - Background: Stem cell factor (SCF) and its receptor, c-kit, are modulators of angiogenesis. Neonatal hyperoxia-induced lung injury (HILI) is characterized by disordered angiogenesis. The objective of this study was to determine whether exogenous SCF improves recovery from neonatal HILI by improving angiogenesis. Methods: Newborn rats assigned to normoxia (RA: 20.9% O2) or hyperoxia (90% O2) from postnatal day (P) 2 to 15, received daily injections of SCF 100 μg/kg or placebo (PL) from P15 to P21. Lung morphometry was performed at P28. Capillary tube formation in SCF-treated hyperoxia-exposed pulmonary microvascular endothelial cells (HPMECs) was determined by Matrigel assay. Results: As compared with RA, hyperoxic-PL pups had decrease in alveolarization and in lung vascular density, and this was associated with increased right ventricular systolic pressure (RVSP), right ventricular hypertrophy, and vascular remodeling. In contrast, SCF-treated hyperoxic pups had increased angiogenesis, improved alveolarization, and attenuation of pulmonary hypertension as evidenced by decreased RVSP, right ventricular hypertrophy, and vascular remodeling. Moreover, in an in vitro model, SCF increased capillary tube formation in hyperoxia-exposed HPMECs. Conclusion: Exogenous SCF restores alveolar and vascular structure in neonatal rats with HILI by promoting neoangiogenesis. These findings suggest a new strategy to treat lung diseases characterized by dysangiogenesis.

AB - Background: Stem cell factor (SCF) and its receptor, c-kit, are modulators of angiogenesis. Neonatal hyperoxia-induced lung injury (HILI) is characterized by disordered angiogenesis. The objective of this study was to determine whether exogenous SCF improves recovery from neonatal HILI by improving angiogenesis. Methods: Newborn rats assigned to normoxia (RA: 20.9% O2) or hyperoxia (90% O2) from postnatal day (P) 2 to 15, received daily injections of SCF 100 μg/kg or placebo (PL) from P15 to P21. Lung morphometry was performed at P28. Capillary tube formation in SCF-treated hyperoxia-exposed pulmonary microvascular endothelial cells (HPMECs) was determined by Matrigel assay. Results: As compared with RA, hyperoxic-PL pups had decrease in alveolarization and in lung vascular density, and this was associated with increased right ventricular systolic pressure (RVSP), right ventricular hypertrophy, and vascular remodeling. In contrast, SCF-treated hyperoxic pups had increased angiogenesis, improved alveolarization, and attenuation of pulmonary hypertension as evidenced by decreased RVSP, right ventricular hypertrophy, and vascular remodeling. Moreover, in an in vitro model, SCF increased capillary tube formation in hyperoxia-exposed HPMECs. Conclusion: Exogenous SCF restores alveolar and vascular structure in neonatal rats with HILI by promoting neoangiogenesis. These findings suggest a new strategy to treat lung diseases characterized by dysangiogenesis.

UR - http://www.scopus.com/inward/record.url?scp=84890666094&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890666094&partnerID=8YFLogxK

U2 - 10.1038/pr.2013.165

DO - 10.1038/pr.2013.165

M3 - Article

C2 - 24153399

AN - SCOPUS:84890666094

VL - 74

SP - 682

EP - 688

JO - Pediatric Research

JF - Pediatric Research

SN - 0031-3998

IS - 6

ER -